Primaquine Phosphate (Alvogen, Inc.)
Welcome to the PulseAid listing for the Primaquine Phosphate drug offered from Alvogen, Inc.. This Antimalarial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alvogen, Inc. |
NON-PROPRIETARY NAME: | Primaquine Phosphate |
SUBSTANCE NAME: | PRIMAQUINE PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimalarial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-08 |
END MARKETING DATE: | 0000-00-00 |
Primaquine Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Primaquine Phosphate from Alvogen, Inc. |
LABELER NAME: | Alvogen, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 26.3(mg/1) |
START MARKETING DATE: | 2011-12-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 47781-331_1333abef-2b71-3b54-679c-ec20b5047b65 |
PRODUCT NDC: | 47781-331 |
APPLICATION NUMBER: | ANDA203924 |
Other PRIMAQUINE PHOSPHATE Pharmaceutical Manufacturers / Labelers: